Defence Therapeutics (DTCFF)
OTHER OTC:DTCFF
Holding DTCFF?
Track your performance easily

Defence Therapeutics (DTCFF) Financial Statements

9 Followers

Defence Therapeutics Financial Overview

Defence Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.227; its P/E ratio is -1.59; Defence Therapeutics is scheduled to report earnings on November 22, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -1.23MC$ -8.26MC$ -2.10MC$ -1.73MC$ -1.23M
EBITDAC$ -1.21MC$ -8.25MC$ -2.09MC$ -1.73MC$ -1.23M
Net Income Common StockholdersC$ -1.33MC$ -8.32MC$ -2.20MC$ -1.73MC$ -1.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 514.53KC$ 351.00KC$ 1.35MC$ 2.79MC$ 2.88M
Total AssetsC$ 968.28KC$ 668.85KC$ 1.59MC$ 3.53MC$ 3.15M
Total DebtC$ 1.60MC$ 1.51MC$ 1.64MC$ 1.75MC$ 1.64M
Net DebtC$ 1.09MC$ 1.16MC$ 287.80KC$ -1.05MC$ -1.24M
Total LiabilitiesC$ 3.27MC$ 2.96MC$ 2.03MC$ 1.97MC$ 1.82M
Stockholders EquityC$ -2.30MC$ -2.30MC$ -441.54KC$ 1.57MC$ 1.33M
Cash Flow-
Free Cash FlowC$ -1.15MC$ -1.39MC$ -1.43MC$ -2.15MC$ -1.81M
Operating Cash FlowC$ -940.92KC$ -1.39MC$ -1.42MC$ -2.15MC$ -1.81M
Investing Cash FlowC$ -213.68K-C$ -6.50KC$ -5.03K-
Financing Cash FlowC$ 1.32MC$ 394.52KC$ -14.66KC$ 2.07MC$ 4.52M
Currency in CAD

Defence Therapeutics Earnings and Revenue History

Defence Therapeutics Debt to Assets

Defence Therapeutics Cash Flow

Defence Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis